Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
Quick Stats
Apr 02, 202649.4
AI Score
HOLD0.71
Volume Ratio
May 05, 2026
Next Earnings
10
+ve Days (30d)
19
-ve Days (30d)
LAB Stock Summary
Last updated Apr 02, 2026
LAB is currently trading at $0.9079, positioned below its 200-day moving average of $1.28, suggesting bearish momentum. The stock has a 52-week range of $0.88 to $1.72.
Technical Analysis: The 50-day moving average stands at $1.13, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 32.382, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.246, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates LAB at 49.4/100 with a HOLD recommendation.
LAB (Standard BioTools Inc. Common Stock) Indicators
Last updated Apr 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 32.382 |
| CMF (20) | -0.246 |
| ROC (10) | -5.427 |
| ADX (14) | 20.989 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.056 |
| AROONOSC (14) | -35.714 |
| WILLAMS %R (14) | -78.538 |
| MFI (14) | 49.316 |
LAB Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
LAB Price vs Max Options Open Interest
LAB Max Change In Options Open Interest
LAB Options - Sort by Max open Interest (near term)
3rd April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
LAB Daily Out of Money Options - Sort by Max open Interest (near term)
3rd April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
LAB Daily In the Money Options - Sort by Max open Interest (near term)
3rd April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
LAB Most Active Options by Volume(near term)
3rd April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Standard BioTools Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
LAB Moving Averages Analysis
LAB (Standard BioTools Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Apr 02, 2026
| Days | MA |
|---|---|
| 10 | 0.94 |
| 20 | 0.95 |
| 30 | 1.0 |
| 50 | 1.13 |
| 100 | 1.27 |
| 200 | 1.28 |
LAB Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 358.2 million |
| Earnings/Share ($) | -0.15 |
| Net Proft Margin (%) | -0.8777 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.05 |
| EPS Estimate Next Year ($) | -0.03 |
| WallStreet Target Price ($) | 1.55 |
| Most Recent Quarter |